NOV 17, 2020 3:30 PM PST

Antibiotics Before Age 2 Linked to Childhood Health Conditions

WRITTEN BY: Annie Lennon

Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased risk for various conditions, including ADHD, allergies, and obesity. 

For the study, the researchers examined data from over 14,500 children from the Rochester Epidemiology Project. The children were born between January 1st, 2003, and December 31st, 2011. Around 70% had received at least one treatment of antibiotics for illness before the age of two.

In the end, the researchers found that early exposure to antibiotics was linked to a higher risk for a range of conditions. These included childhood-onset asthma, allergic rhinitis, atopic dermatitis, celiac disease, overweightedness, obesity, and ADHD. The development of different disorders seemed to be linked to the number, type, and timing of exposure to antibiotics. Furthermore, they found that children exposed to the drugs were more likely to have a combination of conditions. 

The researchers speculate that the reason for this correlation may be linked to the microbiome, which is particularly sensitive in infants. While the effects of antibiotics may be transient, they say that the drugs may have long-term negative effects on health nevertheless. 

“We want to emphasize that this study shows association ― not causation ― of these conditions,” says Nathan LeBrasseur, Ph.D., senior author if the study. “These findings offer the opportunity to target future research to determine more reliable and safer approaches to timing, dosing, and types of antibiotics for children in this age group.”

The researchers hope their findings will go on to inform guidelines for physicians on the safest way to administer antibiotics early in life. This comes especially given recent increases in the incidence of some of the childhood conditions mentioned in the study- although early antibiotic usage has not been established as direct causation. 

 

Sources: Neuroscience NewsMayo Clinic Proceedings

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
New Drug Shows Promise in Treating Advanced COVID-19
SEP 20, 2020
New Drug Shows Promise in Treating Advanced COVID-19
As the COVID-19 pandemic rages on, the search for drugs to combat the virus is ongoing. Now, scientists have found that ...
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
OCT 07, 2020
Technology
Millimeter-Precision Drug Delivery
OCT 07, 2020
Millimeter-Precision Drug Delivery
It is almost impossible to deliver targeted drug therapy via the bloodstream without reaching the entire brain and body ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
Loading Comments...